Compare EVT & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EVT | OMCL |
|---|---|---|
| Founded | 2003 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Computer Manufacturing |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.5B |
| IPO Year | N/A | 2001 |
| Metric | EVT | OMCL |
|---|---|---|
| Price | $24.32 | $36.14 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $42.00 |
| AVG Volume (30 Days) | 115.5K | ★ 390.5K |
| Earning Date | 01-01-0001 | 10-30-2025 |
| Dividend Yield | ★ 8.32% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 6.63 | 0.43 |
| Revenue | $69,404,302.00 | ★ $1,177,740,000.00 |
| Revenue This Year | N/A | $7.89 |
| Revenue Next Year | N/A | $3.50 |
| P/E Ratio | ★ $3.55 | $84.95 |
| Revenue Growth | N/A | ★ 10.67 |
| 52 Week Low | $19.20 | $22.66 |
| 52 Week High | $25.83 | $47.84 |
| Indicator | EVT | OMCL |
|---|---|---|
| Relative Strength Index (RSI) | 52.47 | 59.82 |
| Support Level | $23.00 | $34.79 |
| Resistance Level | $24.55 | $37.69 |
| Average True Range (ATR) | 0.39 | 1.25 |
| MACD | 0.06 | -0.03 |
| Stochastic Oscillator | 69.55 | 64.41 |
EATON VANCE TAX ADVANTAGED DIVIDEND INCOME FUND is a diversified, closed-end management investment company. Its objective is to provide a high level of after-tax total return consisting mainly of tax-advantaged dividend income and capital appreciation. The fund pursues its objective by investing in dividend-paying common and preferred stocks. Its portfolio of investments consists of electric utilities, energy equipment and services, food products, health care providers and services, internet software and services, and other areas.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.